Open access · Peer reviewed · No APCs
Review ArticleJournal of Pharmacology and PharmacotherapeuticsVol. 5 | Issue 4 | 2014 | pp. 227–231Open access
Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon
- 1,
- 2*,
- 3,
- 4
- 1 Department of Internal Medicine, The Commonwealth Medical College.
- 2 Department of Anesthesiology and Intensive Care Medicine, Gian Sagar Medical College, Patiala, Punjab, India.
- 3 Department of Internal Medicine, Wright Center, College.
- 4 Department of Emergency Medicine, Regional Hospital of Scranton, Scranton, Pennsylvania, USA.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sukhminder Jit Singh Bajwa
Department of Anesthesiology and Intensive Care Medicine, Gian Sagar Medical College, Patiala, Punjab, India.
Email: sukhminder_bajwa2001@yahoo.com
Copyright: © 2014 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2014
- Received:
- Feb 22, 2014
- Accepted:
- Jan 16, 2014
How to cite
Sehgal, V., Bajwa, S. J. S., Sehgal, R., & Consalvo, J. A. (2014). Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon. Journal of Pharmacology and Pharmacotherapeutics, 5(4), 227–231. https://doi.org/10.4103/0976-500X.142428
Abstract
Canagliflozin is the first available oral inhibitor of sodium/glucose cotransporter 2 (SGLT2) in the market. At the outset it sounds excellent for the use in the elderly diabetic population, because of its minimal tendency to cause hypoglycemia. However, the clinician needs to exercise caution as it needs to be dosed renally. The clinician needs to be circumspect about potential drug interactions, especially when there is an underlying chronic kidney disease (CKD) and congestive heart failure (CHF). Also its use is best avoided in people who are predisposed to genital mycotic and urinary tract infections (UTI).
Keywords
Subject
Article metadata
| Title | Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon |
|---|---|
| Authors | Vishal Sehgal; Sukhminder Jit Singh Bajwa; Rinku Sehgal; John A Consalvo |
| Affiliations | Department of Internal Medicine, The Commonwealth Medical College.; Department of Anesthesiology and Intensive Care Medicine, Gian Sagar Medical College, Patiala, Punjab, India.; Department of Internal Medicine, Wright Center, College.; Department of Emergency Medicine, Regional Hospital of Scranton, Scranton, Pennsylvania, USA. |
| Corresponding author | sukhminder_bajwa2001@yahoo.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 5, Issue 4 (2014) |
Also in this issue
- Push, promote or educate…musings of a pharmacologist on drug promotionpp. 225–226
- Acetylated and propionated derivatives of swertiamarin have anti‑adipogenic effectspp. 232–238
- Oral carvedilol in escalating doses in the acute treatment of atrial fibrillationpp. 239–244
- The impact of irrational practices: A wake up callpp. 245–247
- Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospitalpp. 248–250
Readers Also Viewed
Effect of the Fractions of Coccinia grandis on Ethanol- Induced Cerebral Oxidative Stress in Rats
M. Umamaheswari, T. K. Chatterjee
Jan 1, 2009
Phytochemical Screening and Antioxidant Activity Evaluation of Selected Philippine Fruit Peels and Pulps
Mildred Dagcuta Pates, Angelo Mark Po Walag, Romeo M. Del Rosario
Aug 17, 2026
Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Review
Jehath Syed, Christy Thomas, Bavneet Kaur
Oct 23, 2026